According to Zhitong Finance App, Meirui Health International (02327.HK) announced that on January 8, 2026, the company (as the buyer) plans to acquire all of Jiangsu Yide's shares from Yuye Group and Ms. Tan Wensheng (as seller) at a total cost of RMB 125 million. On the same day, Mr. Zhou Xuzhou (as the guarantor) signed a letter of guarantee to provide the company with a personal guarantee to ensure that the seller fulfils its obligations under the share transfer agreement. After the acquisition is completed, the company will hold all of Jiangsu Yide's shares. As a result, Jiangsu Yide will become a wholly-owned subsidiary of the company, and its financial results will be incorporated into the Group's comprehensive financial statements.

According to Zhitong Finance App, Meirui Health International (02327.HK) announced that on January 8, 2026, the company (as the buyer) plans to acquire all of Jiangsu Yide's shares from Yuye Group and Ms. Tan Wensheng (as seller) at a total cost of RMB 125 million. On the same day, Mr. Zhou Xuzhou (as the guarantor) signed a letter of guarantee to provide the company with a personal guarantee to ensure that the seller fulfils its obligations under the share transfer agreement. After the acquisition is completed, the company will hold all of Jiangsu Yide's shares. As a result, Jiangsu Yide will become a wholly-owned subsidiary of the company, and its financial results will be incorporated into the Group's comprehensive financial statements.